Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders Equity - Part-2 (Details)

v3.25.1
Stockholders Equity - Part-2 (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Mar. 01, 2025
shares
Sep. 16, 2024
$ / shares
shares
Jul. 11, 2024
$ / shares
shares
Dec. 11, 2023
$ / shares
shares
Nov. 09, 2023
USD ($)
Oct. 29, 2023
USD ($)
$ / shares
shares
Oct. 19, 2023
$ / shares
shares
Aug. 21, 2023
$ / shares
shares
Mar. 01, 2023
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
shares
Feb. 25, 2025
$ / shares
shares
Jan. 01, 2025
shares
Jul. 09, 2024
shares
Mar. 15, 2024
$ / shares
shares
Dec. 31, 2019
shares
Nov. 30, 2017
shares
Stockholders Equity [Line Items]                                  
Exercise price (in Dollars per share) | $ / shares                   $ 0.01              
Common stock, shares outstanding [1]                   18,176,661 4,723,380            
Weighted average exercise price, granted (in Dollars per share) | $ / shares                   $ 3.63              
Vesting period term                   2 years 10 months 24 days              
Stock option price per share (in Dollars per share) | $ / shares       $ 2.75   $ 2.75                      
Option exercised period           1 year                      
Fair value vested amount (in Dollars) | $           $ 167                      
Aggregate shares       15,083                          
Stock-based compensation expense (in Dollars) | $                   $ 1,848 $ 1,059            
Grant of options                   1,567,795              
Fair value of stock option (in Dollars) | $                   $ 4,870 552            
Unrecognized compensation cost (in Dollars) | $                   $ 3,585              
Warrants issued                   12,271,132              
Private Placement Warrants [Member]                                  
Stockholders Equity [Line Items]                                  
Exercise price (in Dollars per share) | $ / shares [2]                   $ 2.31              
Aggregate warrants                   10,820,850              
Warrants issued [2]                   10,820,850              
Warrant [Member]                                  
Stockholders Equity [Line Items]                                  
Stock-based compensation expense (in Dollars) | $                   $ 1,273              
Aggregate warrants                             952,381    
Agents Warrants [Member]                                  
Stockholders Equity [Line Items]                                  
Exercise price (in Dollars per share) | $ / shares                   $ 2.31              
Warrants issued                   952,381              
Minimum [Member]                                  
Stockholders Equity [Line Items]                                  
Common stock, shares outstanding                   18,021,173              
Vesting period term         3 years                        
Stock option exchange ratio         1.4                        
Maximum [Member]                                  
Stockholders Equity [Line Items]                                  
Common stock, shares outstanding                   178,958,447              
Vesting period term         4 years                        
Stock option exchange ratio         3.8                        
Common Stock [Member]                                  
Stockholders Equity [Line Items]                                  
Outstanding share percentage                           15.00%   4.00%  
Common stock, shares outstanding                           7,800,000      
Aggregate warrants                             216,650    
Warrants issued                   25,298              
Common Stock [Member] | Private Placement Warrants [Member]                                  
Stockholders Equity [Line Items]                                  
Aggregate warrants                   50              
2019 Plan [Member]                                  
Stockholders Equity [Line Items]                                  
Granted shares                               1,000  
Issuance of common stock                   5,818,677              
Options granted 154,300         15,110 4,100 8,200                  
Weighted average exercise price, granted (in Dollars per share) | $ / shares           $ 2.75 $ 3.2 $ 3.63 $ 4                
Vesting period term           4 years 4 years 4 years 4 years                
Aggregate shares       69,487                          
PIPE [Member] | Agents Warrants [Member]                                  
Stockholders Equity [Line Items]                                  
Exercise price (in Dollars per share) | $ / shares                             $ 2.31    
Equity Option [Member]                                  
Stockholders Equity [Line Items]                                  
Stock-based compensation expense (in Dollars) | $         $ 19                        
Restricted Stock Units (RSUs) [Member]                                  
Stockholders Equity [Line Items]                                  
RSU granted   155,429                              
Restricted stock unit fair value (in Dollars per share) | $ / shares   $ 0.99                              
BiomX [Member]                                  
Stockholders Equity [Line Items]                                  
Original exercise price (in Dollars per share) | $ / shares           $ 6.9                      
Founder [Member]                                  
Stockholders Equity [Line Items]                                  
Warrants issued                                 298
Subsequent Event [Member]                                  
Stockholders Equity [Line Items]                                  
Aggregate warrants                       6,955,528          
Subsequent Event [Member] | 2019 Plan [Member]                                  
Stockholders Equity [Line Items]                                  
Granted shares                         727,066        
Board of Directors [Member]                                  
Stockholders Equity [Line Items]                                  
Weighted average exercise price, granted (in Dollars per share) | $ / shares     $ 3.63                            
Vesting period term     4 years                            
Grant of options     1,567,795                            
Chief Executive Officer [Member]                                  
Stockholders Equity [Line Items]                                  
Stock-based compensation expense (in Dollars) | $                   $ 811 $ 722            
Forecast [Member] | Private Placement Warrants [Member]                                  
Stockholders Equity [Line Items]                                  
Exercise price (in Dollars per share) | $ / shares                       $ 0.93          
[1] All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split as discussed in Note 12A.
[2] On February 25, 2025, the Private Placement Warrants were repriced to an exercise price of $0.93 per share in connection with a Securities Purchase Agreement the Company entered into. See Note 19 for further information.